"My policy as a doctor was always to be very open and transparent – whether that was about morbidity or mortality I was very open.”
In this latest instalment of the In Vivo podcast, Treehill Partners founder, CEO and chair Ali Pashazadeh focuses on the need for increased communication between biotech and pharma and their contract organizations (both research and development/manufacturing organizations). Pashazadeh also analyzes how his previous medical experience guides him now, as he attempts to transfer the same ethos held as a doctor and clinician to the world of investment banking.
Timestamps:
- Introduction - 00:00
- Clinal development optimization model - 2:37
- Transferring between industries – 7:06
- To what extent will AI impact research? - 11:56
- China and the importance of early data - 15:23
- Looking ahead - 16:35
